SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-22-020722
Filing Date
2022-07-29
Accepted
2022-07-29 17:42:59
Documents
5
Period of Report
2022-07-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 326355
2 formpdef14a_001.jpg GRAPHIC 3095
3 formdef14a_002.jpg GRAPHIC 847
4 proxycard_001.jpg GRAPHIC 291777
5 proxycard_002.jpg GRAPHIC 459617
  Complete submission text file 0001493152-22-020722.txt   1367760
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38306 | Film No.: 221122131
SIC: 2834 Pharmaceutical Preparations